Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Relapsing Multiple Sclerosis”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Large-scale testing (Phase 3)Temporarily pausedNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT02290444
What this trial is testing

Effects of Acthar on Recovery From Cognitive Relapses in MS

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 64
Not applicableStudy completedNCT00888277
What this trial is testing

Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

Who this might be right for
Multiple Sclerosis, Relapsing-remittingMultiple Sclerosis, Secondary Progressive
University of Louisville 74
Early research (Phase 1)Ended earlyNCT02326935
What this trial is testing

Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
American CryoStem Corporation 2
Testing effectiveness (Phase 2)Study completedNCT01448252
What this trial is testing

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hadassah Medical Organization 30
Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Not applicableUnknownNCT03552211
What this trial is testing

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
University Hospital, Clermont-Ferrand 3,000
Not applicableStudy completedNCT01804647
What this trial is testing

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Who this might be right for
Multiple Sclerosis (MS)Relapsing-Remitting MSPrimary Progressive MS+2 more
GeNeuro Innovation SAS 58
Testing effectiveness (Phase 2)Study completedNCT02988401
What this trial is testing

Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 105
Post-approval studies (Phase 4)Study completedNCT01970410
What this trial is testing

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

Who this might be right for
Multiple Sclerosis
Providence Health & Services 55
Not applicableActive Not RecruitingNCT03983681
What this trial is testing

Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

Who this might be right for
Multiple Sclerosis
Kessler Foundation 120
Not applicableStudy completedNCT06737419
What this trial is testing

Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)Study completedNCT01639300
What this trial is testing

Safety Study of GNbAC1 in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 10
Early research (Phase 1)Study completedNCT00559702
What this trial is testing

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Biogen 76
Not applicableEnded earlyNCT02266121
What this trial is testing

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary-progressive Multiple SclerosisCognitive Deficits+1 more
University Hospital of Mont-Godinne 100
Load More Results